Maintenance olaparib after platinum-based chemotherapy in patients (pts) with newly diagnosed advanced ovarian cancer (OC) and a BRCA mutation (BRCAm): Efficacy by surgical and tumor status in the Phase III SOLO1 trial.
暂无分享,去创建一个
A. Oza | M. Friedlander | Byoung-Gie Kim | C. Aghajanian | A. Leary | N. Colombo | G. Scambia | A. Floquet | C. Gourley | P. DiSilvestro | G. Sonke | R. Bloomfield | W. Bradley | E. Lowe | A. Oaknin | A. Lisyanskaya | S. Banerjee | K. Moore | A. González-Martín | C. Mathews